Citizens analyst Aaron Kimson lowered the firm’s price target on Blend Labs (BLND) to $5 from $7 and keeps an Outperform rating on the shares. The company reported “strong” Q4 results but its Q1 guidance is “disappointing,” the analyst tells investors in a research note. Citizens reduced estimates but says the financial institution customers Blend serves will want to stay in the mortgage business.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLND: